Dilip Surana, the man behind dolo, buys Rs 66 crore bungalow in Bengaluru

-

Dilip Surana, the Managing Director (MD) and chairman of Micro Labs, a healthcare company, has purchased a bungalow in Bengaluru for Rs 66 crore. This is considered to be among the most expensive property deals in the city. The development was notified by the real estate data analytics firm CRE Matrix, as per media reports.

The bungalow, along with the land it sits on, measures 8,373.99 sq. ft. It is located in Fair Field layout along Devaraj Urs Road, formerly known as Race Course Road, with a total area of 12,043 sq. ft., as per the sale deed. On 8 March, a stamp duty of Rs 3.36 crore was paid for the registration of the deal, as per the sale deed, which identifies Dilip Surana and his wife Archana Surana as the buyers.

Two decades ago, the Surana family resided in rented homes in Bengaluru, as they chose to live frugally in accordance with the belief of their father, GC Surana. He believed in reinvesting every earned rupee back into the company, prioritising the growth of his business over material possessions such as cars and houses.

Today, Dilip Surana and Anand Surana are at the helm of the company that their father founded. The company now operates 17 factories and has business operations in 50 countries, showcasing the success of their father’s vision and their own leadership.

The company gained widespread attention during the COVID-19 pandemic due to their flagship product, Dolo-650. In 2020, their earnings from selling this product alone amounted to Rs 400 crore in just one year. Prior to the pandemic, they used to sell 7.5 crore strips of Dolo. However, during the pandemic, this number doubled, reflecting a significant increase in demand. As a result, between March 2019 and March 2021, the company’s profits experienced a remarkable surge of 244 per cent.

GC Khurana, the company’s founder, originally relocated from Rajasthan to Bengaluru in pursuit of employment as an accountant. He eventually became a distributor for a company based in Delhi. In 1973, he established Micro Labs with a modest selection of only five products. He placed a strong emphasis on maintaining high quality standards, and his unwavering focus was on competing with multinational companies in terms of product quality.

Read all the Latest News, Trending News, Cricket News, Bollywood News,
India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.



from Firstpost India Latest News https://ift.tt/O2tGVT8
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more